Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
boston blog main
boston top stories
depression
4
×
life sciences
national blog main
national top stories
new york blog main
4
×
new york top stories
biotech
clinical trials
san francisco blog main
san francisco top stories
blackstone group
boston
boulder/denver blog main
boulder/denver top stories
david goldstein
detroit blog main
detroit top stories
epilepsy
essential tremor
fda
indiana blog main
indiana top stories
kiran reddy
major depressive disorder
national
perimenopausal depression
praxis precision medicines
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
steven petrou
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
What
new
drugs
genetic
medicines
praxis
precision
research
way
aims
backed
bio
biopharma
biotechs
cancer
cause
centers
central
ceo
cns
congress
congressional
crispr
cut
depression
disorder
emerged
epilepsy
event
executives
feud
genes
group
guesswork
guide
helps
ipos
isn’t
kept
known
later
Language
unset
Current search:
depression
×
photo
×
" new york blog main "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?
